Cite

HARVARD Citation

    Hoffmann, C. et al. (n.d.). Higher rates of neuropsychiatric adverse events leading to dolutegravir discontinuation in women and older patients. HIV medicine. 18 (1), pp. 56-63. [Online]. 
  
Back to record